VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 101 filers reported holding VERVE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,085,157 | -16.5% | 4,832,968 | +18.1% | 0.00% | 0.0% |
| Q2 2023 | $76,710,282 | +37.1% | 4,091,215 | +5.5% | 0.00% | +100.0% |
| Q1 2023 | $55,933,017 | -24.2% | 3,878,850 | +1.8% | 0.00% | -50.0% |
| Q4 2022 | $73,762,664 | -41.3% | 3,812,024 | +4.2% | 0.00% | -50.0% |
| Q3 2022 | $125,680,000 | +251.2% | 3,658,812 | +56.2% | 0.00% | +300.0% |
| Q2 2022 | $35,789,000 | -32.4% | 2,342,193 | +1.0% | 0.00% | 0.0% |
| Q1 2022 | $52,915,000 | +5.2% | 2,318,775 | +70.0% | 0.00% | 0.0% |
| Q4 2021 | $50,300,000 | -16.6% | 1,364,221 | +6.4% | 0.00% | 0.0% |
| Q3 2021 | $60,279,000 | +1438.9% | 1,282,542 | +1873.1% | 0.00% | – |
| Q2 2021 | $3,917,000 | – | 65,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $167,683,000 | 9.10% |
| ARCH Venture Management, LLC | 2,508,809 | $38,335,000 | 4.67% |
| Casdin Capital, LLC | 3,138,167 | $47,951,000 | 4.05% |
| M28 Capital Management LP | 178,500 | $2,727,000 | 3.06% |
| Redmile Group, LLC | 1,833,547 | $28,017,000 | 1.07% |
| Cormorant Asset Management, LP | 700,710 | $10,707,000 | 0.81% |
| Novo Holdings A/S | 927,100 | $14,166,000 | 0.70% |
| Pinz Capital Management, LP | 51,800 | $792,000 | 0.54% |
| PFM Health Sciences, LP | 845,186 | $12,914,000 | 0.49% |
| Artal Group S.A. | 400,000 | $6,112,000 | 0.33% |